BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12
| Image |  |
|---|---|
| Description | scientific article published on 06 December 2019 |
| Author/s |
author: Adam Witkowski Shigeru Saito Ron Waksman |
| Publication date | December 6, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |